Last reviewed · How we verify
Double trigger
At a glance
| Generic name | Double trigger |
|---|---|
| Also known as | Augmented trigger |
| Sponsor | Riyadh Fertility and Reproductive Health center |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
- Upper Respiratory Symptoms or Upper Respiratory Tract Infection
- Lead Migration
- Fall or Trip or Slip or Twist
- Sleepiness
- Skin reaction
- Bronchitis
Key clinical trials
- IncobotulinumtoxinA for Provoked Vestibulodynia With Overactive Pelvic Floor Muscle Dysfunction (PHASE2)
- Selatogrel Outcome Study in Suspected Acute Myocardial Infarction (PHASE3)
- Topical Ketotifen 0.25% for Secondary Vestibulodynia (PHASE2)
- Effect of Two Different Fluid Treatment Regimens on Ultrasonographic Upper Airway Measurements (NA)
- Efficacy of Triamcinolone-Lidocaine Mix in Trigger Points Injection of Masseter Muscle: Double-blinded, Randomized Controlled Trial (PHASE2, PHASE3)
- Closed Loop DBS Implanted RC+S Study (NA)
- A Phase 2 Study to Evaluate the Efficacy and Safety of Pudafensine in Vulvodynia (Provoked Vestibulodynia) (PHASE2)
- Sensory Feeding and Parent Coaching for Children With ARFID (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |